Assessment of Rituximab Therapeutic Response Versus Conventional Treatment
NCT05553496
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Pharmacological Action
Interventions
DRUG:
Rituximab
DRUG:
Dexamethasone
Sponsor
Ain Shams University